Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma.
Cancer Discov. 2022 Aug 5;12(8):1886-1903. doi: 10.1158/2159-8290.CD-21-1586.
Cancer Discov. 2022.
PMID: 35554512
Free PMC article.
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's Lymphoma.
Giraudo MF, Jackson Z, Das I, Abiona OM, Wald DN.
Giraudo MF, et al.
Pathog Immun. 2024 Mar 15;9(1):1-17. doi: 10.20411/pai.v9i1.647. eCollection 2024.
Pathog Immun. 2024.
PMID: 38550613
Free PMC article.
Review.
Item in Clipboard
Cite
Cite